Your browser doesn't support javascript.
loading
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma.
Eertink, Jakoba J; Zwezerijnen, Gerben J C; Wiegers, Sanne E; Pieplenbosch, Simone; Chamuleau, Martine E D; Lugtenburg, Pieternella J; de Jong, Daphne; Ylstra, Bauke; Mendeville, Matias; Dührsen, Ulrich; Hanoun, Christine; Hüttmann, Andreas; Richter, Julia; Klapper, Wolfram; Jauw, Yvonne W S; Hoekstra, Otto S; de Vet, Henrica C W; Boellaard, Ronald; Zijlstra, Josée M.
Afiliação
  • Eertink JJ; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Zwezerijnen GJC; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Wiegers SE; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Pieplenbosch S; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Chamuleau MED; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Lugtenburg PJ; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • de Jong D; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Ylstra B; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Mendeville M; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Dührsen U; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Hanoun C; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Hüttmann A; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Richter J; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Klapper W; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Jauw YWS; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Hoekstra OS; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • de Vet HCW; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Boellaard R; Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Zijlstra JM; Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Blood Adv ; 7(2): 214-223, 2023 01 24.
Article em En | MEDLINE | ID: mdl-36306337
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-myc / Linfoma Difuso de Grandes Células B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-myc / Linfoma Difuso de Grandes Células B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda